CYTUNE
LIVE

Serial Number

90389015

Owner

Cytune Pharma S.A.S.

Attorney

Shane Rumbaugh

Filing Date

Dec 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CYTUNE Trademark

Serial Number: 90389015 • Registration: 6849176

CYTUNE is a trademark filed by Cytune Pharma S.A.S. on December 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cytune Pharma S.A.S.

3, Chemin du Pressoir ChĂȘnaie
Nantes F-44100 , FR

Entity Type: 99

Trademark Details

Filing Date

December 17, 2020

Registration Date

September 20, 2022

Published for Opposition

July 5, 2022

Goods & Services

Pharmaceuticals, medical and veterinary preparations for the prevention and treatment of neoplasia, tumors, cancer and infectious diseases; anticancer preparations; antitumor drugs in the nature of tumor suppressing agents; vaccines; anticancer vaccines; pharmaceutical preparations for the treatment of neoplasia, tumors, cancer and infectious diseases, namely, peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs for medical and veterinary purposes; biological preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; cellular preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; radiopharmaceutical preparations for the treatment of neoplasia, tumors and cancer for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and infectious diseases; diagnostic agents, preparations and test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; drug delivery agents; adjuvants for medical use; dietetic substances adapted for medical use

Medical services; medical diagnostic services

Scientific and technological services, namely, research and design in the field of biotechnological and pharmaceutical research and development; industrial analysis and research services in the field of biotechnological and pharmaceutical research and development; scientific research for medical and veterinary purposes; scientific research and development for medical and veterinary purposes in the area of cancerous diseases, autoimmune diseases and infectious diseases; pharmaceutical drug development services; conducting clinical trials for others; scientific preclinical and clinical research in the field of prevention and treatment of neoplasia, tumors, cancer and infectious diseases; scientific preclinical and clinical research in the fields of biologics and chemotherapy; analysis of toxicology and mode of action of biological and chemicals and combinations on animals; pharmaceutical and biological product research, development, safety testing, and quality control testing services for others; scientific research and development for diagnostic purposes; computer-aided diagnostic testing services in the nature of computer diagnostic services; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2025 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 16, 2024 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 20, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 20, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 5, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 5, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 15, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 7, 2022 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 31, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 11, 2022 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 28, 2021 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 27, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 27, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 27, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 27, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 27, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2021 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 18, 2021 CHAN
ASSIGNED TO LIE
Dec 15, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2021 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 30, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 30, 2021 REAP
ASSIGNED TO EXAMINER
Sep 29, 2021 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 18, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 18, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 18, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 11, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 27, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2021 NWOS
NEW APPLICATION ENTERED
Dec 21, 2020 NWAP